vs
艾仕得（AXTA）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是艾仕得的1.1倍（$1.4B vs $1.3B），艾仕得净利率更高（4.8% vs 3.6%，领先1.1%），通用电气医疗同比增速更快（12.2% vs -3.7%），艾仕得自由现金流更多（$286.0M vs $130.2M），过去两年通用电气医疗的营收复合增速更高（13.0% vs -1.2%）
艾仕得是源自美国的专业涂料供应商，总部位于宾夕法尼亚州费城，注册地为百慕大。公司主营乘用车、商用车、工业场景及修补用途涂料的研发与生产，业务覆盖全球130个国家，拥有近1.3万名员工，服务超10万家客户。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
AXTA vs OPCH — 直观对比
营收规模更大
OPCH
是对方的1.1倍
$1.3B
营收增速更快
OPCH
高出16.0%
-3.7%
净利率更高
AXTA
高出1.1%
3.6%
自由现金流更多
AXTA
多$155.8M
$130.2M
两年增速更快
OPCH
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.4B |
| 净利润 | $60.0M | $51.8M |
| 毛利率 | 33.4% | 19.0% |
| 营业利润率 | 12.8% | 5.9% |
| 净利率 | 4.8% | 3.6% |
| 营收同比 | -3.7% | 12.2% |
| 净利润同比 | -56.2% | -3.8% |
| 每股收益（稀释后） | $0.28 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXTAOPCH
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.4B | $1.2B | ||
| Q1 24 | $1.3B | $1.1B |
净利润AXTAOPCH
| Q4 25 | $60.0M | — | ||
| Q3 25 | $110.0M | $51.8M | ||
| Q2 25 | $109.0M | $50.5M | ||
| Q1 25 | $99.0M | $46.7M | ||
| Q4 24 | $137.0M | $60.1M | ||
| Q3 24 | $101.0M | $53.9M | ||
| Q2 24 | $112.0M | $53.0M | ||
| Q1 24 | $41.0M | $44.8M |
毛利率AXTAOPCH
| Q4 25 | 33.4% | — | ||
| Q3 25 | 34.9% | 19.0% | ||
| Q2 25 | 35.0% | 19.0% | ||
| Q1 25 | 34.3% | 19.7% | ||
| Q4 24 | 34.1% | 21.3% | ||
| Q3 24 | 35.0% | 20.1% | ||
| Q2 24 | 34.0% | 20.3% | ||
| Q1 24 | 33.2% | 20.8% |
营业利润率AXTAOPCH
| Q4 25 | 12.8% | — | ||
| Q3 25 | 15.8% | 5.9% | ||
| Q2 25 | 14.8% | 5.8% | ||
| Q1 25 | 13.9% | 5.9% | ||
| Q4 24 | 14.3% | 6.9% | ||
| Q3 24 | 14.6% | 6.7% | ||
| Q2 24 | 15.2% | 6.6% | ||
| Q1 24 | 9.4% | 6.0% |
净利率AXTAOPCH
| Q4 25 | 4.8% | — | ||
| Q3 25 | 8.5% | 3.6% | ||
| Q2 25 | 8.4% | 3.6% | ||
| Q1 25 | 7.8% | 3.5% | ||
| Q4 24 | 10.5% | 4.8% | ||
| Q3 24 | 7.7% | 4.2% | ||
| Q2 24 | 8.3% | 4.3% | ||
| Q1 24 | 3.2% | 3.9% |
每股收益（稀释后）AXTAOPCH
| Q4 25 | $0.28 | — | ||
| Q3 25 | $0.51 | $0.32 | ||
| Q2 25 | $0.50 | $0.31 | ||
| Q1 25 | $0.45 | $0.28 | ||
| Q4 24 | $0.63 | $0.36 | ||
| Q3 24 | $0.46 | $0.31 | ||
| Q2 24 | $0.51 | $0.30 | ||
| Q1 24 | $0.18 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $657.0M | $309.8M |
| 总债务越低越好 | $3.2B | $1.2B |
| 股东权益账面价值 | $2.3B | $1.4B |
| 总资产 | $7.6B | $3.5B |
| 负债/权益比越低杠杆越低 | 1.36× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资AXTAOPCH
| Q4 25 | $657.0M | — | ||
| Q3 25 | $606.0M | $309.8M | ||
| Q2 25 | $625.0M | $198.8M | ||
| Q1 25 | $575.0M | $171.4M | ||
| Q4 24 | $593.0M | $412.6M | ||
| Q3 24 | $567.0M | $483.0M | ||
| Q2 24 | $840.0M | $376.9M | ||
| Q1 24 | $624.0M | $219.5M |
总债务AXTAOPCH
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.4B | $1.2B | ||
| Q2 25 | $3.4B | $1.1B | ||
| Q1 25 | $3.4B | $1.1B | ||
| Q4 24 | $3.4B | $1.1B | ||
| Q3 24 | $3.5B | $1.1B | ||
| Q2 24 | $3.6B | $1.1B | ||
| Q1 24 | $3.4B | $1.1B |
股东权益AXTAOPCH
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.3B | $1.4B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $1.9B | $1.4B | ||
| Q3 24 | $1.9B | $1.4B | ||
| Q2 24 | $1.8B | $1.4B | ||
| Q1 24 | $1.7B | $1.4B |
总资产AXTAOPCH
| Q4 25 | $7.6B | — | ||
| Q3 25 | $7.8B | $3.5B | ||
| Q2 25 | $7.8B | $3.4B | ||
| Q1 25 | $7.4B | $3.3B | ||
| Q4 24 | $7.2B | $3.4B | ||
| Q3 24 | $7.5B | $3.4B | ||
| Q2 24 | $7.3B | $3.3B | ||
| Q1 24 | $7.1B | $3.2B |
负债/权益比AXTAOPCH
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.48× | 0.86× | ||
| Q2 25 | 1.50× | 0.82× | ||
| Q1 25 | 1.64× | 0.82× | ||
| Q4 24 | 1.78× | 0.79× | ||
| Q3 24 | 1.84× | 0.78× | ||
| Q2 24 | 2.02× | 0.79× | ||
| Q1 24 | 1.97× | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $344.0M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | $286.0M | $130.2M |
| 自由现金流率自由现金流/营收 | 22.7% | 9.1% |
| 资本支出强度资本支出/营收 | 4.6% | 0.6% |
| 现金转化率经营现金流/净利润 | 5.73× | 2.69× |
| 过去12个月自由现金流最近4个季度 | $453.0M | $220.7M |
8季度趋势，按日历期对齐
经营现金流AXTAOPCH
| Q4 25 | $344.0M | — | ||
| Q3 25 | $137.0M | $139.4M | ||
| Q2 25 | $142.0M | $90.3M | ||
| Q1 25 | $26.0M | $-7.2M | ||
| Q4 24 | $234.0M | $36.1M | ||
| Q3 24 | $194.0M | $160.4M | ||
| Q2 24 | $114.0M | $195.7M | ||
| Q1 24 | $34.0M | $-68.8M |
自由现金流AXTAOPCH
| Q4 25 | $286.0M | — | ||
| Q3 25 | $87.0M | $130.2M | ||
| Q2 25 | $97.0M | $81.2M | ||
| Q1 25 | $-17.0M | $-16.6M | ||
| Q4 24 | $172.0M | $25.8M | ||
| Q3 24 | $161.0M | $150.7M | ||
| Q2 24 | $91.0M | $185.9M | ||
| Q1 24 | $12.0M | $-74.6M |
自由现金流率AXTAOPCH
| Q4 25 | 22.7% | — | ||
| Q3 25 | 6.8% | 9.1% | ||
| Q2 25 | 7.4% | 5.7% | ||
| Q1 25 | -1.3% | -1.2% | ||
| Q4 24 | 13.1% | 2.0% | ||
| Q3 24 | 12.2% | 11.8% | ||
| Q2 24 | 6.7% | 15.1% | ||
| Q1 24 | 0.9% | -6.5% |
资本支出强度AXTAOPCH
| Q4 25 | 4.6% | — | ||
| Q3 25 | 3.9% | 0.6% | ||
| Q2 25 | 3.4% | 0.6% | ||
| Q1 25 | 3.4% | 0.7% | ||
| Q4 24 | 4.7% | 0.8% | ||
| Q3 24 | 2.5% | 0.8% | ||
| Q2 24 | 1.7% | 0.8% | ||
| Q1 24 | 1.7% | 0.5% |
现金转化率AXTAOPCH
| Q4 25 | 5.73× | — | ||
| Q3 25 | 1.25× | 2.69× | ||
| Q2 25 | 1.30× | 1.79× | ||
| Q1 25 | 0.26× | -0.15× | ||
| Q4 24 | 1.71× | 0.60× | ||
| Q3 24 | 1.92× | 2.98× | ||
| Q2 24 | 1.02× | 3.69× | ||
| Q1 24 | 0.83× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXTA
| Refinish | $509.0M | 40% |
| Light Vehicle | $372.0M | 29% |
| Industrial | $282.0M | 22% |
| Commercial Vehicle | $99.0M | 8% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
